Abstract
The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Current Vascular Pharmacology
Title: Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Volume: 7 Issue: 2
Author(s): Joseph Varon and Albert T. Cheung
Affiliation:
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Abstract: The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Export Options
About this article
Cite this article as:
Varon Joseph and Cheung T. Albert, Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care, Current Vascular Pharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157016109787455590
DOI https://dx.doi.org/10.2174/157016109787455590 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ZnO@SnO2 Mixed Metal Oxide as an Efficient and Recoverable Nanocatalyst for the Solvent Free Synthesis of Hantzsch 1,4-Dihydropyridines
Letters in Organic Chemistry Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design A New Role for Zn(II) Aminopeptidases: Antigenic Peptide Generation and Destruction
Current Pharmaceutical Design Urine IL-18 is a Biomarker of Early Acute Kidney Injury (AKI)
Recent Patents on Biomarkers Novel Caffeic Acid Phenethyl Ester (Cape) Analogues as Inducers of Heme Oxygenase-1
Current Pharmaceutical Design Signal Transduction in HIV Protein-Treated Astrocytes
Current Signal Transduction Therapy Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets Vulnerable Atherosclerotic Plaque: Clinical Implications
Current Vascular Pharmacology Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead
Current Diabetes Reviews Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Current Pharmaceutical Design Endothelial Effects of Drugs Designed to Treat Erectile Dysfunction
Current Pharmaceutical Design Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Clinical Pharmacology of Frequently Used Intravenous Drugs During Bariatric Surgery in Adolescents
Current Pharmaceutical Design Targeting the Human Thioredoxin System by Diverse Strategies to Treat Cancer and Other Pathologies
Recent Patents on DNA & Gene Sequences Synthesis and Antithrombotic Activity Study of Some New Thienopyridine Derivatives
Letters in Organic Chemistry Loop Gain and Sleep Disordered Breathing
Current Respiratory Medicine Reviews Beyond Mitochondria, What Would be the Energy Source of the Cell?
Central Nervous System Agents in Medicinal Chemistry Lipid-lowering Therapy in the Diabetic Foot: Seeing the Whole Iceberg and not Just the Tip
Current Vascular Pharmacology Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine